APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pertussis Vaccine

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.

Selected research

Market Structure

Global Pertussis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

9 January 2026185 pages

Choose your research edition.

Industry ResearchPertussis Vaccine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Pertussis Vaccine Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Pertussis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pertussis Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pertussis Vaccine Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.

Global pertussis vaccine key players include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology etc. Global top 2 manufacturers hold a share about 90%. Europe is the largest market, with a share over 30%, followed by North America.

This report provides an overview of the global Pertussis Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Pertussis Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pertussis Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pertussis Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Pertussis Vaccine Segment by Company

Sanofi Pasteur

GSK

Mitsubishi Tanabe Pharma

Wuhan Institute of Biological Products

Walvax Biotechnology

Minhai Biotechnology

KM Biologics

Chengdu Institute of Biological Products

Pertussis Vaccine Segment by Type

Whole-cell Vaccines

Acellular Vaccines

Pertussis Vaccine Segment by Application

12 Months Below

12 Months Above

Pertussis Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pertussis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pertussis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pertussis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pertussis Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pertussis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pertussis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pertussis Vaccine Industry Trends Table 2. Pertussis Vaccine Industry Drivers Table 3. Pertussis Vaccine Industry Opportunities and Challenges Table 4. Pertussis Vaccine Industry Restraints Table 5. Global Pertussis Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pertussis Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pertussis Vaccine Sales by Manufacturers (M Doses) & (2021-2026) Table 8. Global Pertussis Vaccine Sales Market Share by Manufacturers Table 9. Global Pertussis Vaccine Average Sales Price (USD/Doses) of Manufacturers (2021-2026) Table 10. Global Pertussis Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pertussis Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pertussis Vaccine Manufacturers, Product Type & Application Table 13. Global Pertussis Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pertussis Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Whole-cell Vaccines Table 17. Major Manufacturers of Acellular Vaccines Table 18. Global Pertussis Vaccine Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 19. Global Pertussis Vaccine Sales by Type (2021-2026) & (M Doses) Table 20. Global Pertussis Vaccine Sales by Type (2027-2032) & (M Doses) Table 21. Global Pertussis Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Pertussis Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Pertussis Vaccine Revenue by Type 2021 VS 2025 VS 2032 (M Doses) Table 24. Global Pertussis Vaccine Revenue by Type (2021-2026) & (M Doses) Table 25. Global Pertussis Vaccine Revenue by Type (2027-2032) & (M Doses) Table 26. Global Pertussis Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Pertussis Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of 12 Months Below Table 29. Major Manufacturers of 12 Months Above Table 30. Global Pertussis Vaccine Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 31. Global Pertussis Vaccine Sales by Application (2021-2026) & (M Doses) Table 32. Global Pertussis Vaccine Sales by Application (2027-2032) & (M Doses) Table 33. Global Pertussis Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Pertussis Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Pertussis Vaccine Revenue by Application 2021 VS 2025 VS 2032 (M Doses) Table 36. Global Pertussis Vaccine Revenue by Application (2021-2026) & (M Doses) Table 37. Global Pertussis Vaccine Revenue by Application (2027-2032) & (M Doses) Table 38. Global Pertussis Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Pertussis Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Pertussis Vaccine Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Table 41. Global Pertussis Vaccine Sales by Region (2021-2026) & (M Doses) Table 42. Global Pertussis Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Pertussis Vaccine Sales Forecasted by Region (2027-2032) & (M Doses) Table 44. Global Pertussis Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Pertussis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 46. North America Pertussis Vaccine Sales by Country (2021-2026) & (M Doses) Table 47. North America Pertussis Vaccine Sales by Country (2027-2032) & (M Doses) Table 48. Europe Pertussis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 49. Europe Pertussis Vaccine Sales by Country (2021-2026) & (M Doses) Table 50. Europe Pertussis Vaccine Sales by Country (2027-2032) & (M Doses) Table 51. Asia Pacific Pertussis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 52. Asia Pacific Pertussis Vaccine Sales by Country (2021-2026) & (M Doses) Table 53. Asia Pacific Pertussis Vaccine Sales by Country (2027-2032) & (M Doses) Table 54. South America, Middle East and Africa Pertussis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 55. South America, Middle East and Africa Pertussis Vaccine Sales by Country (2021-2026) & (M Doses) Table 56. South America, Middle East and Africa Pertussis Vaccine Sales by Country (2027-2032) & (M Doses) Table 57. Global Pertussis Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Pertussis Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Pertussis Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Pertussis Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Pertussis Vaccine Revenue Market Share by Region (2027-2032) Table 62. Sanofi Pasteur Company Information Table 63. Sanofi Pasteur Business Overview Table 64. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Sanofi Pasteur Pertussis Vaccine Product Portfolio Table 66. Sanofi Pasteur Recent Development Table 67. GSK Company Information Table 68. GSK Business Overview Table 69. GSK Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. GSK Pertussis Vaccine Product Portfolio Table 71. GSK Recent Development Table 72. Mitsubishi Tanabe Pharma Company Information Table 73. Mitsubishi Tanabe Pharma Business Overview Table 74. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio Table 76. Mitsubishi Tanabe Pharma Recent Development Table 77. Wuhan Institute of Biological Products Company Information Table 78. Wuhan Institute of Biological Products Business Overview Table 79. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio Table 81. Wuhan Institute of Biological Products Recent Development Table 82. Walvax Biotechnology Company Information Table 83. Walvax Biotechnology Business Overview Table 84. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Walvax Biotechnology Pertussis Vaccine Product Portfolio Table 86. Walvax Biotechnology Recent Development Table 87. Minhai Biotechnology Company Information Table 88. Minhai Biotechnology Business Overview Table 89. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Minhai Biotechnology Pertussis Vaccine Product Portfolio Table 91. Minhai Biotechnology Recent Development Table 92. KM Biologics Company Information Table 93. KM Biologics Business Overview Table 94. KM Biologics Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. KM Biologics Pertussis Vaccine Product Portfolio Table 96. KM Biologics Recent Development Table 97. Chengdu Institute of Biological Products Company Information Table 98. Chengdu Institute of Biological Products Business Overview Table 99. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio Table 101. Chengdu Institute of Biological Products Recent Development Table 102. Key Raw Materials Table 103. Raw Materials Key Suppliers Table 104. Pertussis Vaccine Distributors List Table 105. Pertussis Vaccine Customers List Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. Pertussis Vaccine Product Image Figure 2. Global Pertussis Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pertussis Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Pertussis Vaccine Sales (2021-2032) & (M Doses) Figure 5. Global Pertussis Vaccine Average Price (USD/Doses) & (2021-2032) Figure 6. Global Top 5 and 10 Pertussis Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Whole-cell Vaccines Image Figure 9. Acellular Vaccines Image Figure 10. Global Pertussis Vaccine Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 11. Global Pertussis Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Pertussis Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Pertussis Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 14. Global Pertussis Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Pertussis Vaccine Revenue Market Share by Type (2021-2032) Figure 16. 12 Months Below Image Figure 17. 12 Months Above Image Figure 18. Global Pertussis Vaccine Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 19. Global Pertussis Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Pertussis Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Pertussis Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 22. Global Pertussis Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Pertussis Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 25. North America Pertussis Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 27. Canada Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 28. Mexico Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 29. Europe Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 30. Europe Pertussis Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 32. France Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 33. U.K. Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 34. Italy Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 35. Netherlands Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 36. Asia Pacific Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 37. Asia Pacific Pertussis Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 39. Japan Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 40. South Korea Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 41. Southeast Asia Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 42. India Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 43. Australia Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 44. South America, Middle East and Africa Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 45. South America, Middle East and Africa Pertussis Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 47. South Africa Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 48. Saudi Arabia Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 49. Turkey Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 50. Argentina Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 51. UAE Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 52. Egypt Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 53. Chile Pertussis Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 54. Global Pertussis Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Pertussis Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Pertussis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Pertussis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Pertussis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Pertussis Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Pertussis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Pertussis Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Pertussis Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Whole-cell Vaccines
  • Acellular Vaccines
Applications
  • 12 Months Below
  • 12 Months Above
Companies covered
  • Sanofi Pasteur
  • GSK
  • Mitsubishi Tanabe Pharma
  • Wuhan Institute of Biological Products
  • Walvax Biotechnology
  • Minhai Biotechnology
  • KM Biologics
  • Chengdu Institute of Biological Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pertussis Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pertussis Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pertussis Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pertussis Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pertussis Vaccine Market Dynamics
  1. 2.1 Pertussis Vaccine Industry Trends
  2. 2.2 Pertussis Vaccine Industry Drivers
  3. 2.3 Pertussis Vaccine Industry Opportunities and Challenges
  4. 2.4 Pertussis Vaccine Industry Restraints
3 Pertussis Vaccine Market by Manufacturers
  1. 3.1 Global Pertussis Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pertussis Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pertussis Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pertussis Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pertussis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pertussis Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Pertussis Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pertussis Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pertussis Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pertussis Vaccine Tier 1, Tier 2, and Tier 3
4 Pertussis Vaccine Market by Type
  1. 4.1 Pertussis Vaccine Type Introduction
  2. 4.1.1 Whole-cell Vaccines
  3. 4.1.2 Acellular Vaccines
  4. 4.2 Global Pertussis Vaccine Sales by Type
  5. 4.2.1 Global Pertussis Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pertussis Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Pertussis Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Pertussis Vaccine Revenue by Type
  9. 4.3.1 Global Pertussis Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pertussis Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Pertussis Vaccine Revenue Market Share by Type (2021-2032)
5 Pertussis Vaccine Market by Application
  1. 5.1 Pertussis Vaccine Application Introduction
  2. 5.1.1 12 Months Below
  3. 5.1.2 12 Months Above
  4. 5.2 Global Pertussis Vaccine Sales by Application
  5. 5.2.1 Global Pertussis Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pertussis Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Pertussis Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Pertussis Vaccine Revenue by Application
  9. 5.3.1 Global Pertussis Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Pertussis Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Pertussis Vaccine Revenue Market Share by Application (2021-2032)
6 Global Pertussis Vaccine Sales by Region
  1. 6.1 Global Pertussis Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pertussis Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Pertussis Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Pertussis Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pertussis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pertussis Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pertussis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pertussis Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pertussis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pertussis Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pertussis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pertussis Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pertussis Vaccine Revenue by Region
  1. 7.1 Global Pertussis Vaccine Revenue by Region
  2. 7.1.1 Global Pertussis Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pertussis Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Pertussis Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Pertussis Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pertussis Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Pertussis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pertussis Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Pertussis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pertussis Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pertussis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pertussis Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pertussis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi Pasteur
  2. 8.1.1 Sanofi Pasteur Company Information
  3. 8.1.2 Sanofi Pasteur Business Overview
  4. 8.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio
  6. 8.1.5 Sanofi Pasteur Recent Developments
  7. 8.2 GSK
  8. 8.2.1 GSK Company Information
  9. 8.2.2 GSK Business Overview
  10. 8.2.3 GSK Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GSK Pertussis Vaccine Product Portfolio
  12. 8.2.5 GSK Recent Developments
  13. 8.3 Mitsubishi Tanabe Pharma
  14. 8.3.1 Mitsubishi Tanabe Pharma Company Information
  15. 8.3.2 Mitsubishi Tanabe Pharma Business Overview
  16. 8.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
  18. 8.3.5 Mitsubishi Tanabe Pharma Recent Developments
  19. 8.4 Wuhan Institute of Biological Products
  20. 8.4.1 Wuhan Institute of Biological Products Company Information
  21. 8.4.2 Wuhan Institute of Biological Products Business Overview
  22. 8.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
  24. 8.4.5 Wuhan Institute of Biological Products Recent Developments
  25. 8.5 Walvax Biotechnology
  26. 8.5.1 Walvax Biotechnology Company Information
  27. 8.5.2 Walvax Biotechnology Business Overview
  28. 8.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio
  30. 8.5.5 Walvax Biotechnology Recent Developments
  31. 8.6 Minhai Biotechnology
  32. 8.6.1 Minhai Biotechnology Company Information
  33. 8.6.2 Minhai Biotechnology Business Overview
  34. 8.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio
  36. 8.6.5 Minhai Biotechnology Recent Developments
  37. 8.7 KM Biologics
  38. 8.7.1 KM Biologics Company Information
  39. 8.7.2 KM Biologics Business Overview
  40. 8.7.3 KM Biologics Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 KM Biologics Pertussis Vaccine Product Portfolio
  42. 8.7.5 KM Biologics Recent Developments
  43. 8.8 Chengdu Institute of Biological Products
  44. 8.8.1 Chengdu Institute of Biological Products Company Information
  45. 8.8.2 Chengdu Institute of Biological Products Business Overview
  46. 8.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
  48. 8.8.5 Chengdu Institute of Biological Products Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pertussis Vaccine Value Chain Analysis
  2. 9.1.1 Pertussis Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pertussis Vaccine Production Mode & Process
  6. 9.2 Pertussis Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pertussis Vaccine Distributors
  9. 9.2.3 Pertussis Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst